Subclinical carotid atherosclerosis in patients with familial combined hyperlipidemia. Two years follow-up after treatment with high doses of atorvastatin;Arteriosclerosis carotídea subclínica en pacientes con hiperlipidemia familiar combinada. Evolución tras dos años de tratamiento con dosis altas de atorvastatina

Medicina Clinica

Volumn 138, Issue 1, 2012, Pages 1-6

  Martínez Hervás, Sergio ^a,b   Priego, Antonia ^a   Lorente, Rosario ^a   Molina, Mercedes ^a   Navarro Hidalgo, M Inmaculada ^a   Real, José T ^a,b   Ascaso, Juan F ^a,b  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Atherosclerosis; Atorvastatin; Carotid artery; Familial combined hyperlipidemia; Intima media thickness

Indexed keywords

ATORVASTATIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; CAROTID ATHEROSCLEROSIS; CLINICAL TRIAL; DISEASE MARKER; DISEASE SEVERITY; DRUG MEGADOSE; FAMILIAL COMBINED HYPERLIPIDEMIA; FAMILIAL HYPERLIPEMIA; FOLLOW UP; HUMAN; INTERVENTION STUDY; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; PRIMARY PREVENTION; REGRESSION ANALYSIS; THICKNESS; TREATMENT DURATION;

ANTICHOLESTEREMIC AGENTS; CAROTID ARTERY DISEASES; FEMALE; HEPTANOIC ACIDS; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; PYRROLES; STATISTICS, NONPARAMETRIC;

EID: 84855814909     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2010.12.009     Document Type: Article

References (23)

1. S. Martínez-Hervás, J.T. Real, A. Priego, J. Sanz, J.M. Martín, and R. Carmena Familial combined hyperlipidemia, metabolic syndrome and cardiovascular disease Rev Esp Cardiol. 59 2006 1195 1198 (Pubitemid 46139217)
2. C. Pitsavos, I. Skoumas, C. Masoura, K. Aznaouridis, L. Papadimitriou, and C. Chrysohoou Prevalence and determinants of coronary artery disease in males and females with familial combined hyperlipidaemia Atherosclerosis. 199 2008 402 407
3. L. Masana Which cardiovascular risk tables should we use? Rev Esp Cardiol. 60 2007 690 692 (Pubitemid 47394946)
4. E. De Groot, G.K. Hovingh, A. Wiegman, P. Duriez, A.J. Smit, and J.C. Fruchart Measurement of arterial wall thickness as a surrogate marker for atherosclerosis Circulation. 109 2004 III33 38
5. D.H. O'Leary, J.F. Polak, R.A. Kronmal, T.A. Manolio, G.L. Burke, and S.K. Wolfson Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group N Engl J Med. 340 1999 14 22 (Pubitemid 29024679)
6. M.L. Bots, A.W. Hoes, P.J. Koudstaal, A. Hofman, and D.E. Grobbee Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study Circulation. 96 1997 1432 1437 (Pubitemid 27375333)
7. M. Junyent Usefulness of carotid ultrasonography in the evaluation of the effectiveness of hypolipidemic therapy Med Clin (Barc). 133 2009 135 136
8. R.D. Santos, and K. Nasir Insights into atherosclerosis from invasive and non-invasive imaging studies: Should we treat subclinical atherosclerosis? Atherosclerosis. 205 2009 349 356
9. M.J. Veerkamp, J. De Graaf, S.J. Bredie, J.C. Hendriks, P.N. Demacker, and A.F. Stalenhoef Diagnosis of familial combined hyperlipidemia based on lipid phenotype expression in 32 families: results of a 5-year follow-up study Arterioscler Thromb Vasc Biol. 22 2002 274 282 (Pubitemid 34127039)
10. S. Martinez-Hervas, P. Romero, E.B. Hevilla, J.T. Real, A. Priego, and J.M. Martin-Moreno Classical cardiovascular risk factors according to fasting plasma glucose levels Eur J Intern Med. 19 2008 209 213 (Pubitemid 351452112)
11. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia. 28 1985 412 419 (Pubitemid 15018832)
12. P.J. Touboul, M.G. Hennerici, S. Meairs, H. Adams, P. Amarenco, and N. Bornstein Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006 Cerebrovasc Dis. 23 2007 75 80 (Pubitemid 46112808)
13. R.A. Wyman, M.E. Mays, P.E. McBride, and J.H. Stein Ultrasound-detected carotid plaque as a predictor of cardiovascular events Vasc Med. 11 2006 123 130 (Pubitemid 44122770)
14. P. Greenland, J. Abrams, G.P. Aurigemma, M.G. Bond, L.T. Clark, and M.H. Criqui Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III Circulation. 101 2000 E16 22
15. A.J. Taylor, S.M. Kent, P.J. Flaherty, L.C. Coyle, T.T. Markwood, and M.N. Vernalis ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness Circulation. 106 2002 2055 2060 (Pubitemid 35192810)
16. J.R. Crouse, 3rd, J.S. Raichlen, W.A. Riley, G.W. Evans, M.K. Palmer, and D.H. O'Leary Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial JAMA. 297 2007 1344 1353 (Pubitemid 46513235)
17. G.C. Makris, A. Lavida, A.N. Nicolaides, and G. Geroulakos The effect of statins on carotid plaque morphology: A LDL-associated action or one more pleiotropic effect of statins? Atherosclerosis 231 2010 8 20
18. P.H. Jones, M.H. Davidson, E.A. Stein, H.E. Bays, J.M. McKenney, and E. Miller Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial) Am J Cardiol. 92 2003 152 160 (Pubitemid 36835963)
19. J.J. Kastelein, E. De Groot, and R. Sankatsing Atherosclerosis measured by B-mode ultrasonography: effect of statin therapy on disease progression Am J Med. 116 Suppl 6A 2004 31S 36S
20. M. Mercuri, M.G. Bond, C.R. Sirtori, F. Veglia, G. Crepaldi, and F.S. Feruglio Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic mediterranean population: the Carotid Atherosclerosis Italian Ultrasound Study Am J Med. 101 1996 627 634 (Pubitemid 27150041)
21. E. De Groot, J.W. Jukema, A.D. Montauban van Swijndregt, A.H. Zwinderman, R.G. Ackerstaff, and A.F. Van der Steen B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: a report of the Regression Growth Evaluation Statin Study (REGRESS) J Am Coll Cardiol. 31 1998 1561 1567 (Pubitemid 28273299)
22. M. Junyent, R. Gilabert, I. Nunez, E. Corbella, M. Vela, and D. Zambon Carotid ultrasound in the assessment of preclinical atherosclerosis Distribution of intima-media thickness values and plaque frequency in a Spanish community cohort. Med Clin (Barc). 125 2005 770 774
23. C. Lahoz, J.M. Mostaza, M.A. San Martín, M.F. García Iglesias, M. Frias, and A. García Grosor de la íntima-media carotídea en la hipercolesterolemia familiar heterocigótica: factores asociados y variación al año de tratamiento Med Clin. 133 2009 121 126